See more : SEEK Limited (SKLTF) Income Statement Analysis – Financial Results
Complete financial analysis of Orthofix Medical Inc. (OFIX) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Orthofix Medical Inc., a leading company in the Medical – Devices industry within the Healthcare sector.
You may be interested
- América Móvil, S.A.B. de C.V. (AMXVF) Income Statement Analysis – Financial Results
- LightJump Acquisition Corporation (LJAQU) Income Statement Analysis – Financial Results
- Fox Marble Holdings PLC (FOX.L) Income Statement Analysis – Financial Results
- Teqnion AB (publ) (TEQ.ST) Income Statement Analysis – Financial Results
- Danske Invest Globale High Yield Obligationer (DKIGHYB.CO) Income Statement Analysis – Financial Results
Orthofix Medical Inc. (OFIX)
About Orthofix Medical Inc.
Orthofix Medical Inc. operates as a medical device and biologics company in the United States, Italy, Germany, France, the United Kingdom, Brazil, and internationally. It operates through two segments, Global Spine and Global Orthopedics. The Global Spine segment manufactures, distributes, and provides support services for bone growth stimulator devices that enhance bone fusion, as well as used as a therapeutic treatment for non-spinal and appendicular fractures. This segment also designs, develops, and markets a portfolio of motion preservation and fixation implant products, which are used in surgical procedures of the spine; and a portfolio of products and tissue forms that allow physicians to treat a range of spinal and orthopedic conditions, as well as markets regenerative non-tissue biologic solutions derived from synthetic materials. The Global Orthopedics segment designs, develops, and markets orthopedic products that are used in fracture repair, deformity correction, and bone reconstruction procedures. The company markets and distributes its products through direct sales representatives; independent distributors; and employed and independent sales representatives to physicians, hospitals, ambulatory surgery centers, integrated health delivery systems, and other purchasing organizations. The company was formerly known as Orthofix International N.V. and changed its name to Orthofix Medical Inc. in July 2018. Orthofix Medical Inc. was founded in 1980 and is headquartered in Lewisville, Texas.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993 | 1992 | 1991 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 746.64M | 460.71M | 464.48M | 406.56M | 459.96M | 453.04M | 433.82M | 409.79M | 396.49M | 402.28M | 400.53M | 462.32M | 578.99M | 564.37M | 545.64M | 519.68M | 490.32M | 365.36M | 313.30M | 286.64M | 203.71M | 177.60M | 162.36M | 131.78M | 121.28M | 104.10M | 90.00M | 77.20M | 52.30M | 39.60M | 31.40M | 28.00M | 20.90M |
| Cost of Revenue | 260.37M | 123.54M | 114.91M | 101.89M | 100.61M | 96.63M | 93.04M | 87.85M | 86.53M | 98.91M | 102.30M | 86.49M | 139.19M | 131.72M | 138.45M | 152.01M | 129.03M | 93.63M | 83.79M | 79.18M | 51.09M | 44.82M | 42.95M | 28.41M | 30.19M | 26.50M | 22.70M | 21.10M | 18.00M | 12.70M | 8.90M | 8.00M | 0.00 |
| Gross Profit | 486.27M | 337.17M | 349.57M | 304.67M | 359.35M | 356.41M | 340.79M | 321.94M | 309.96M | 303.37M | 298.23M | 375.83M | 439.80M | 432.65M | 407.19M | 367.66M | 361.29M | 271.73M | 229.52M | 207.46M | 152.62M | 132.78M | 119.41M | 103.37M | 91.10M | 77.60M | 67.30M | 56.10M | 34.30M | 26.90M | 22.50M | 20.00M | 20.90M |
| Gross Profit Ratio | 65.13% | 73.18% | 75.26% | 74.94% | 78.13% | 78.67% | 78.55% | 78.56% | 78.18% | 75.41% | 74.46% | 81.29% | 75.96% | 76.66% | 74.63% | 70.75% | 73.68% | 74.37% | 73.26% | 72.38% | 74.92% | 74.76% | 73.55% | 78.44% | 75.11% | 74.54% | 74.78% | 72.67% | 65.58% | 67.93% | 71.66% | 71.43% | 100.00% |
| Research & Development | 80.23M | 49.07M | 49.62M | 39.06M | 34.64M | 33.22M | 29.70M | 28.80M | 26.39M | 24.99M | 26.77M | 28.58M | 25.15M | 30.35M | 31.46M | 30.84M | 24.22M | 54.99M | 11.32M | 11.47M | 8.13M | 7.51M | 6.99M | 6.89M | 6.40M | 5.90M | 4.80M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 144.66M | 79.97M | 69.35M | 67.95M | 85.61M | 84.51M | 74.39M | 74.40M | 87.16M | 76.79M | 65.15M | 53.83M | 86.47M | 88.63M | 88.87M | 288.72M | 259.89M | 199.02M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 385.74M | 228.81M | 221.32M | 204.43M | 223.68M | 205.53M | 198.37M | 181.29M | 178.08M | 166.55M | 176.58M | 200.34M | 233.61M | 230.94M | 215.94M | 40.00K | 38.00K | 40.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 530.40M | 308.78M | 290.67M | 272.38M | 309.28M | 290.03M | 272.76M | 255.69M | 265.24M | 243.34M | 241.73M | 254.17M | 320.08M | 319.57M | 304.81M | 288.72M | 259.89M | 199.02M | 151.92M | 133.07M | 97.22M | 81.63M | 77.78M | 62.35M | 54.65M | 49.90M | 44.90M | 43.30M | 24.60M | 14.20M | 11.20M | 10.90M | 0.00 |
| Other Expenses | 14.76M | -3.15M | -3.34M | 8.38M | -8.14M | -6.38M | -4.00M | -17.18M | -259.00K | -2.90M | 490.00K | -3.68M | 5.60M | -6.26M | 7.04M | 305.05M | 18.16M | 8.87M | 6.57M | 7.92M | 6.68M | 703.00K | 4.14M | 4.03M | 6.83M | 6.50M | 6.50M | 6.20M | 2.20M | 1.10M | 700.00K | 800.00K | 0.00 |
| Operating Expenses | 625.38M | 357.84M | 340.29M | 311.44M | 343.92M | 323.25M | 302.46M | 284.49M | 291.63M | 270.62M | 271.18M | 284.85M | 350.82M | 343.66M | 343.31M | 624.61M | 302.26M | 262.88M | 169.81M | 152.46M | 112.03M | 89.84M | 88.91M | 73.27M | 67.88M | 62.30M | 56.20M | 49.50M | 26.80M | 15.30M | 11.90M | 11.70M | 0.00 |
| Cost & Expenses | 885.75M | 481.39M | 455.21M | 413.33M | 444.53M | 419.88M | 395.50M | 372.35M | 378.15M | 369.53M | 373.48M | 371.34M | 490.01M | 475.38M | 481.76M | 776.62M | 431.29M | 356.51M | 253.60M | 231.64M | 163.12M | 134.66M | 131.86M | 101.68M | 98.07M | 88.80M | 78.90M | 70.60M | 44.80M | 28.00M | 20.80M | 19.70M | 0.00 |
| Interest Income | 0.00 | 1.29M | 1.84M | 2.48M | 122.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 326.00K | 330.00K | 193.00K | 542.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 8.63M | 1.29M | 1.84M | 2.48M | 122.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.83M | 0.00 | 9.46M | 17.23M | 24.63M | 20.22M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 60.60M | 29.02M | 29.60M | 30.55M | 24.70M | 18.66M | 20.12M | 20.84M | 20.92M | 2.28M | 22.66M | 20.26M | 22.78M | 22.52M | 22.34M | 32.68M | 32.33M | 16.96M | 17.53M | 15.08M | 6.95M | 5.83M | 7.95M | 7.38M | 6.83M | 6.50M | 6.50M | 6.20M | 2.20M | 1.10M | 700.00K | 800.00K | 0.00 |
| EBITDA | -79.45M | 12.60M | 17.94M | 32.66M | -2.23M | 41.54M | 60.94M | 39.87M | 29.92M | 40.64M | 14.05M | 96.19M | 53.27M | 112.15M | 87.19M | -243.53M | 70.39M | 25.81M | 116.76M | 70.08M | 47.53M | 48.77M | 38.45M | 41.51M | 30.05M | 21.77M | 17.56M | 12.80M | 9.70M | 12.70M | 11.30M | 9.10M | 20.90M |
| EBITDA Ratio | -10.64% | -5.17% | 5.78% | 8.83% | 10.79% | 8.00% | 8.26% | 9.63% | 6.92% | 12.59% | 20.43% | 24.06% | 19.30% | 19.70% | 15.60% | 15.80% | 22.83% | 6.07% | 11.48% | 24.53% | 26.67% | 28.93% | 23.91% | 2.39% | 24.76% | 16.52% | 20.67% | 18.78% | 62.72% | 29.29% | 35.03% | 31.43% | 100.00% |
| Operating Income | -139.11M | -20.67M | -6.23M | 1.62M | 24.94M | 30.09M | 40.81M | 21.07M | 9.26M | 17.14M | -5.09M | 89.01M | 32.52M | 88.99M | 63.88M | -256.95M | 38.06M | 8.85M | 59.71M | 55.00M | 40.58M | 42.94M | 30.50M | 22.73M | 23.22M | 15.30M | 11.10M | 6.60M | 7.50M | 11.60M | 10.60M | 8.30M | 20.90M |
| Operating Income Ratio | -18.63% | -4.49% | -1.34% | 0.40% | 5.42% | 6.64% | 9.41% | 5.14% | 2.33% | 4.26% | -1.27% | 19.25% | 5.62% | 15.77% | 11.71% | -49.44% | 7.76% | 2.42% | 19.06% | 19.19% | 19.92% | 24.18% | 18.78% | 17.24% | 19.14% | 14.70% | 12.33% | 8.55% | 14.34% | 29.29% | 33.76% | 29.64% | 100.00% |
| Total Other Income/Expenses | -9.57M | -4.44M | -5.18M | -366.50K | -8.27M | -7.21M | -4.42M | -2.04M | -748.00K | -4.68M | 589.00K | -7.10M | -33.88M | -10.96M | -23.85M | -38.09M | -23.32M | -2.53M | 35.81M | -4.64M | -1.27M | -2.41M | -1.67M | 38.33M | -2.39M | 1.70M | -3.86M | -4.30M | -24.70M | 300.00K | -300.00K | -800.00K | -20.90M |
| Income Before Tax | -148.68M | -17.71M | -13.50M | -368.00K | -27.05M | 22.89M | 36.39M | 19.02M | 8.51M | 12.46M | -6.52M | 82.73M | 20.70M | 72.40M | 40.02M | -295.04M | 14.80M | 6.32M | 95.52M | 50.36M | 39.32M | 40.53M | 28.83M | 61.05M | 20.83M | 17.00M | 7.20M | 2.30M | -17.20M | 11.90M | 10.30M | 7.50M | 0.00 |
| Income Before Tax Ratio | -19.91% | -3.84% | -2.91% | -0.09% | -5.88% | 5.05% | 8.39% | 4.64% | 2.15% | 3.10% | -1.63% | 17.89% | 3.58% | 12.83% | 7.33% | -56.77% | 3.02% | 1.73% | 30.49% | 17.57% | 19.30% | 22.82% | 17.76% | 46.33% | 17.17% | 16.33% | 8.00% | 2.98% | -32.89% | 30.05% | 32.80% | 26.79% | 0.00% |
| Income Tax Expense | 2.72M | 2.04M | 24.88M | -2.89M | 1.41M | 9.07M | 29.10M | 15.53M | 10.85M | 16.20M | 9.16M | 28.79M | 21.78M | 28.19M | 15.55M | -66.48M | 3.77M | 13.36M | 22.11M | 16.21M | 14.59M | 12.88M | 7.87M | 16.23M | 7.91M | 2.70M | 4.10M | 2.80M | 2.60M | 2.80M | 2.60M | 1.30M | -5.00M |
| Net Income | -151.40M | -19.75M | -38.38M | 2.52M | -28.46M | 13.81M | 6.22M | 3.06M | -2.81M | -8.54M | -28.48M | 51.30M | -1.07M | 44.21M | 24.47M | -228.55M | 10.97M | -7.04M | 73.40M | 34.15M | 24.73M | 25.91M | 20.96M | 44.82M | 12.91M | 14.30M | 3.10M | -500.00K | -19.80M | 9.10M | 7.70M | 6.20M | 5.00M |
| Net Income Ratio | -20.28% | -4.29% | -8.26% | 0.62% | -6.19% | 3.05% | 1.43% | 0.75% | -0.71% | -2.12% | -7.11% | 11.10% | -0.19% | 7.83% | 4.49% | -43.98% | 2.24% | -1.93% | 23.43% | 11.91% | 12.14% | 14.59% | 12.91% | 34.01% | 10.65% | 13.74% | 3.44% | -0.65% | -37.86% | 22.98% | 24.52% | 22.14% | 23.92% |
| EPS | -4.12 | -0.98 | -1.95 | 0.13 | -1.51 | 0.75 | 0.34 | 0.17 | -0.15 | -0.46 | -1.52 | 2.70 | -0.06 | 2.51 | 1.43 | -13.37 | 0.66 | -0.44 | 4.61 | 2.22 | 1.76 | 1.96 | 1.60 | 3.40 | 0.99 | 1.10 | 0.24 | -0.04 | -1.78 | 0.84 | 0.71 | 0.61 | 0.57 |
| EPS Diluted | -4.12 | -0.98 | -1.95 | 0.13 | -1.51 | 0.73 | 0.34 | 0.17 | -0.15 | -0.46 | -1.52 | 2.64 | -0.06 | 2.47 | 1.42 | -13.37 | 0.64 | -0.44 | 4.51 | 2.14 | 1.68 | 1.76 | 1.42 | 3.20 | 0.97 | 1.07 | 0.23 | -0.04 | -1.78 | 0.84 | 0.71 | 0.61 | 0.57 |
| Weighted Avg Shares Out | 36.73M | 20.05M | 19.69M | 19.27M | 18.90M | 18.49M | 18.12M | 18.14M | 18.80M | 18.46M | 18.70M | 18.98M | 18.22M | 17.60M | 17.12M | 17.10M | 16.64M | 16.17M | 15.91M | 15.40M | 14.06M | 13.20M | 13.09M | 13.18M | 13.03M | 12.97M | 12.92M | 12.50M | 11.12M | 10.83M | 10.85M | 10.16M | 8.77M |
| Weighted Avg Shares Out (Dil) | 36.73M | 20.05M | 19.69M | 19.39M | 18.90M | 18.91M | 18.50M | 18.46M | 18.80M | 18.46M | 18.70M | 19.39M | 18.22M | 17.91M | 17.20M | 17.10M | 17.05M | 16.17M | 16.29M | 15.97M | 14.68M | 14.69M | 14.74M | 13.99M | 13.36M | 13.29M | 13.48M | 12.50M | 11.12M | 10.83M | 10.85M | 10.16M | 8.77M |
OFIX Investors Have Opportunity to Lead Orthofix Medical Inc. Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today!
NEW YORK CITY, NY / ACCESSWIRE / October 16, 2024 / Bronstein, Gewirtz & Grossman, LLC a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Orthofix Medical Inc. ("Orthofix" or "the Company") (NASDAQ:OFIX)...
OFIX STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Orthofix Medical Inc. Investors with Losses Have Opportunity to Lead Class Action Lawsuit!
NEW YORK CITY, NY / ACCESSWIRE / October 16, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Orthofix Medical Inc. ("Orthofix" or "the Company") (NASDAQ:OFIX)...
The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of October 21, 2024 in Orthofix Medical Inc. Lawsuit – OFIX
NEW YORK, Oct. 16, 2024 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Orthofix Medical Inc. (NASDAQ: OFIX).
Orthofix Medical Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before October 21, 2024 to Discuss Your Rights – OFIX
NEW YORK, NY / ACCESSWIRE / October 15, 2024 / If you suffered a loss on your Orthofix Medical Inc. (NASDAQ:OFIX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for...
ORTHOFIX MEDICAL SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Orthofix Medical, Inc. - OFIX
NEW ORLEANS, Oct. 15, 2024 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until October 21, 2024 to file lead plaintiff applications...
Levi & Korsinsky Notifies Shareholders of Orthofix Medical Inc.(OFIX) of a Class Action Lawsuit and an Upcoming Deadline
NEW YORK, NY / ACCESSWIRE / October 15, 2024 / If you suffered a loss on your Orthofix Medical Inc. (NASDAQ:OFIX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for...
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Orthofix Medical Inc. (OFIX) Shareholders
NEW YORK, NY / ACCESSWIRE / October 15, 2024 / If you suffered a loss on your Orthofix Medical Inc. (NASDAQ:OFIX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for...
Orthofix Medical Inc. Class Action: Levi & Korsinsky Reminds Orthofix Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 21, 2024 – OFIX
NEW YORK, NY / ACCESSWIRE / October 15, 2024 / If you suffered a loss on your Orthofix Medical Inc. (NASDAQ:OFIX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for...
OFIX Investors Have Opportunity to Lead Orthofix Medical Inc. Securities Fraud Lawsuit
BENSALEM, Pa. , Oct. 15, 2024 /PRNewswire/ -- Law Offices of Howard G.
SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Orthofix Medical Inc. - OFIX
NEW YORK, NY / ACCESSWIRE / October 15, 2024 / Pomerantz LLP announces that a class action lawsuit has been filed against Orthofix Medical Inc. ("Orthofix" or the "Company") (NASDAQ:OFIX). Such investors are advised to contact Danielle Peyton at [email protected]...
Source: https://incomestatements.info
Category: Stock Reports